RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration

Clinical Infectious Diseases

Volumn 61, Issue , 2015, Pages S155-S159

  Hamilton, Carol D ^a,b   Swaminathan, Soumya ^c   Christopher, Devasahayam J ^d   Ellner, Jerrold ^e   Gupta, Amita ^f   Sterling, Timothy R ^g   Rolla, Valeria ^h   Srinivasan, Sudha ⁱ   Karyana, Muhammad ^i,k   Siddiqui, Sophia ⁱ   Stoszek, Sonia K ^j   Kim, Peter ⁱ  

^a FHI 360   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h Funda??o Oswaldo Cruz   (Brazil)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^j Health Studies Sector   (United States)

^k Sub Directorate of Filariasis and Helminthiasis Control Directorate of Vector Borne Disease Control Indonesia Ministry of Health   (Indonesia)

more..

Author keywords

biological markers; biological specimen banks; prospective studies; specimen handling; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON;

ARTICLE; BRAZIL; CASE REPORT; CLINICAL DATA REPOSITORY; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL STUDY; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; GOLD STANDARD; HUMAN; IMMUNE RESPONSE; INDIA; INDONESIA; INTERNATIONAL RELATIONS; JOINT VENTURE; LABORATORY TEST; LUNG TUBERCULOSIS; NUTRITIONAL STATUS; POPULATION GENETICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RELAPSE; SPUTUM CULTURE; STANDARDIZATION; THORAX RADIOGRAPHY; TREATMENT FAILURE; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; TUBERCULOUS MENINGITIS; BIOBANK; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; PROSPECTIVE STUDY; SPECIMEN HANDLING;

BIOLOGICAL SPECIMEN BANKS; BIOMARKERS; BIOMEDICAL RESEARCH; BRAZIL; HUMANS; INDIA; INDONESIA; INTERNATIONAL COOPERATION; PROSPECTIVE STUDIES; SPECIMEN HANDLING; TUBERCULOSIS;

EID: 84943418931     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ611     Document Type: Article

References (9)

1. Wallis RS, Kim P, Cole S, et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 2013; 13:362-72.
2. Nahid P, Saukkonen J, Mac Kenzie WR, et al. CDC/NIH workshop. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med 2011; 184:972-9.
3. McCourt B, Harrington RA, Fox K, et al. Data standards: at the intersection of sites, clinical research networks, and standards development initiatives. Drug Inf J 2007; 41:393-404.
4. TB Alliance. Innovations: discovery of biomarkers (CTB2). Available at: http://www.tballiance.org/pipeline/innovation-detail.phpid=2. Accessed 9 August 2015.
5. Marais BJ, Graham SM, Cotton MF, Beyers N. Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis 2007; 196(suppl 1):S76-85.
6. Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365:2155-66.
7. Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drugsusceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 2002; 360:528-34.
8. O'Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med 1997; 126:939-45.
9. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-54.